Estimated Incidence of All-Cause Respiratory Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Finland between 2011 and 2019: A Retrospective Database Study
Respiratory morbidity and mortality associated with RSV infection among adults in Finland are substantial, particularly for those aged ≥ 75 years. Newly introduced RSV vaccines, which appear effective for the oldest adults, could have a substantial impact on this respiratory disease burden.
Authors
- Pimnara Peerawaranun (ORCID: https://orcid.org/0000-0002-3746-6846)
- Olli-Pekka Hätinen
- Worku Biyadgie Ewnetu (ORCID: https://orcid.org/0000-0002-3650-2016)
- Robin Bruyndonckx (ORCID: https://orcid.org/0000-0002-4217-2869)
- Maribel Casas (ORCID: https://orcid.org/0009-0004-8647-2216)
- Caihua Liang
- Aleksandra Polkowska-Kramek
- Mikel Esnaola
- Bradford D. Gessner
- Mikko Kosunen
- Elizabeth Begier
Institutions
- Pfizer (United States) (US)
- Pfizer (Ireland) (IE)
- KU Leuven (BE)
Publication Details
- Journal
- Journal of Epidemiology and Global Health
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1007/s44197-025-00506-7
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 31.52